SearcharxivSearch

arXiv subjects

Antoni Lorente

Publications and source records attributed to Antoni Lorente.

2 recordsLinked to original sources

Relational Archetypes: A Comparative Analysis of AV-Human and Agent-Human Interactions

Over the last couple of years, AI Agents have gained significant traction due to substantial progress in the capabilities of underlying General Purpose AI (GPAI) models, enhanced scaffolding techniques, and the promise to drive societal transformation. Companies, researchers, and policy makers have started to consider the different effects that AI agents may have across different dimensions of our lives. However, the literature exploring the broader effects of human-agent interactions is still underdeveloped. In this paper, we review the problem of traffic modulation by autonomous vehicles (AVs) in mixed traffic flows and extrapolate the learnings to the different modes of interaction between humans and AVs to the pair humans-AI agents. In doing so, we propose a preliminary taxonomy of relational archetypes based on literature on Human-Computer Interaction (HCI) and AV-human interaction and tentatively explore how the resulting framework may lead to new questions regarding human-agent interactions. Our effort is aimed at strengthening existing bridges between these two research communities, which share similar traits: autonomy, fast adoption, high impact, and great potential for economic transformation. Building on previous analogies between AI Agents and AVs (e.g., regarding autonomy levels), we anticipate this paper to spark scholarly debate on the different types of impact that agents may have on our societies, while inviting other researchers to expand the scope of their comparative analysis regarding AI Agents.

cs.CY

Institutional Review Boards as Soft Governance Mechanisms of R&D: Governing the R&D of AI-based Medical Products

Risk-based approaches to governance bear an ambiguous stance regarding the Research and Development stages of AI, for they the possibility of explicit risks before they are posed by a given finalised product. In this context, Institutional Review Boards (IRBs) stand as unique governance mechanisms, capable of addressing the step from general research to concrete product development. However, IRBs face several challenges in governing AI-based medical products, including: (a) achieving consistency, (b) being exhaustive, (c) ensuring process transparency, and (d) reducing the existing capacity and knowledge asymmetry between different stakeholders. This article explores four governance levers that can be used to effect change, four governance entry-points throughout a product's lifecycle, and five different behaviours that IRBs should try to advance to ensure the effective governance of the R&D stages of AI-based medical projects. In doing so, IRBs can seize the unique opportunity they present to bring principles into practice, increase research quality, reduce governance costs, and bridge the knowledge gap between stakeholders.

cs.CY